Device Trial Radar · NCT04886388
Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes
Last checked: Nov 19, 2026Latest source record: Sep 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
668
Actual
Start
Apr 22, 2021
Primary completion
Mar 9, 2022
Study completion Sep 27, 2022
Sponsor
- Lead sponsor
- Better TherapeuticsNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 14, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
BT-001 is a software program intended to help patients with type 2 diabetes, under the guidance of their physician, improve glycemic control (i.e., levels of blood sugar). The BT-001 software delivers a type of behavioral therapy to patients via a mobile application that targets behaviors related to achieving glycemic control. The effectiveness of BT-001 will be measured by its ability to help patients reduce Hemoglobin A1c, or HbA1c (a marker in the blood that measures blood sugar) compared to standard medical care in patients with type 2 diabetes.
Conditions
- Type 2 Diabetes
Interventions
BT-001Device
BT-001 is a software program intended to help patients with type 2 diabetes, under the guidance of their physician, improve glycemic control.
Physician-guided Standard of Care for type 2 diabetesOther
Current ADA Standard of Care Guidelines for type 2 diabetes
Primary outcomes
What the sponsor says the trial is designed to measure.
- The difference in the mean change from baseline in HbA1c at Day 90 between Intervention and Standard of Care groupsTime frame: Baseline and Day 90
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Study Site
San Francisco, California
Study Site
Miami, Florida
Study Site
Atlanta, Georgia
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.